Glen Harbor Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-228
| Closed | -$115K | – | 1329 |
|
|
2019
Q2 | $115K | Sell |
228
-72
| -24% | -$36.3K | ﹤0.01% | 1146 |
|
|
2019
Q1 | $298K | Sell |
300
-301
| -50% | -$299K | 0.01% | 865 |
|
|
2018
Q4 | $522K | Sell |
601
-287
| -32% | -$249K | 0.01% | 600 |
|
|
2018
Q3 | $918K | Buy |
888
+60
| +7% | +$62K | 0.02% | 501 |
|
|
2018
Q2 | $761K | Buy |
828
+22
| +3% | +$20.2K | 0.02% | 514 |
|
|
2018
Q1 | $786K | Buy |
806
+681
| +545% | +$664K | 0.02% | 470 |
|
|
2017
Q4 | $57K | Sell |
125
-84
| -40% | -$38.3K | ﹤0.01% | 1220 |
|
|
2017
Q3 | $87K | Sell |
209
-27
| -11% | -$11.2K | ﹤0.01% | 1146 |
|
|
2017
Q2 | $83K | Sell |
236
-78
| -25% | -$27.4K | ﹤0.01% | 1125 |
|
|
2017
Q1 | $161K | Hold |
314
| – | – | ﹤0.01% | 788 |
|
|
2016
Q4 | $111K | Buy |
+314
| New | +$111K | ﹤0.01% | 872 |
|